Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRKCA | P17252 | 2/20 | 0.61 |
| ▸ | PRKCD | Q05655 | 2/20 | 0.61 |
| ▸ | MAPT | P10636 | 1/20 | 0.49 |
| ▸ | TP53 | P04637 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | PLA2G4B | P0C869 | 2/20 | 0.45 |
| ▸ | RARB | P10826 | 6/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6429949 | 0.95 | PRKCA (0.56) | PRKCAPRKCDMAPTTP53TSHR | |
| SCHEMBL828598 | 0.94 | PRKCA (0.68) | PRKCAPRKCDMAPTTSHRALDH1A1 | |
| SCHEMBL718186 | 0.91 | PRKCA (0.50) | PRKCAPRKCDMAPTTP53TSHR | |
| SCHEMBL4944754 | 0.90 | PRKCA (0.59) | PRKCAPRKCDMAPTTP53TSHR | |
| SCHEMBL5373207 | 0.89 | TP53 (0.53) | PRKCAPRKCDMAPTTP53TSHR | |
| SCHEMBL16227359 | 0.89 | TP53 (0.53) | PRKCAPRKCDMAPTTP53TSHR | |
| SCHEMBL6673106 | 0.89 | TP53 (0.51) | PRKCAPRKCDMAPTTP53TSHR | |
| SCHEMBL18489570 | 0.89 | PRKCA (0.62) | PRKCAPRKCDTP53TSHRALDH1A1 | |
| SCHEMBL9721791 | 0.89 | PRKCA (0.61) | PRKCAPRKCDMAPTTSHRALDH1A1 | |
| Acrylic Acid SCHEMBL8210114 | 0.88 | PRKCA (0.49) | PRKCAPRKCDMAPTTP53TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3510012-A1 | PROCESSES FOR THE HYDROGENATION OF PHTHALATE ESTERS | ExxonMobil Chemical Patents Inc. (US) | 2019-07-17 | — | — | EP | disclosed |
| US-20190185404-A1 | PROCESSES FOR THE HYDROGENATION OF PHTHALATE ESTERS | EXXONMOBIL CHEMICAL PATENTS INC. | 2019-06-20 | — | — | US | disclosed |
| US-10017448-B2 | Process for hydrogenation of benzenepolycarboxylic acids and derivatives thereof | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2018-07-10 | — | — | US | disclosed |
| WO-2018046306-A1 | PROCESSES FOR THE HYDROGENATION OF PHTHALATE ESTERS | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2018-03-15 | — | — | WO | disclosed |
| US-20170291867-A1 | Improved Process for Hydrogenation of Benzenepolycarboxylic Acids and Derivatives Thereof | EXXONMOBIL CHEMICAL PATENTS INC. | 2017-10-12 | — | — | US | disclosed |
| EP-3212605-A1 | IMPROVED PROCESS FOR HYDROGENATION OF BENZENEPOLYCARBOXYLIC ACIDS AND DERIVITIVES THEREOF | ExxonMobil Chemical Patents Inc. (US) | 2017-09-06 | — | — | EP | disclosed |
| WO-2016066410-A1 | IMPROVED PROCESS FOR HYDROGENATION OF BENZENEPOLYCARBOXYLIC ACIDS AND DERIVITIVES THEREOF | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2016-05-06 | — | — | WO | disclosed |
| EP-1567470-B1 | HYDROGENATION OF BENZENE POLYCARBOXYLIC ACIDS OR DERIVATIVES THEREOF | EXXONMOBIL CHEM PATENTS INC (US) | 2013-06-05 | — | — | EP | disclosed |
| US-8203017-B2 | Hydrogenation of benzene polycarboxylic acids or derivatives thereof | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2012-06-19 | — | — | US | disclosed |
| US-8143438-B2 | Hydrogenation processes | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2012-03-27 | — | — | US | disclosed |
| US-7893295-B2 | Hydrogenation of benzene polycarboxylic acids or derivatives thereof | EXXON MOBIL CHEMICAL PATENTS INC. (US) | 2011-02-22 | — | — | US | disclosed |
| US-7875742-B2 | hydrogenating organic compounds by contacting with hydrogen-containing gas in presence of catalyst which comprises catalytically active metals applied to porous catalyst support; catalytically active metals having been derived via decomposed amine complex of metal on support | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2011-01-25 | — | — | US | disclosed |
| US-20100184895-A1 | Hydrogenation Processes | EXXONMOBOIL RESEARCH AND ENGINEERING COMPANY | 2010-07-22 | — | — | US | disclosed |
| US-7732634-B2 | hydrogenating organic compounds by contacting with hydrogen-containing gas in presence of catalyst which comprises catalytically active metals applied to porous catalyst support; catalytically active metals having been derived via decomposed amine complex of metal on support | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2010-06-08 | — | — | US | disclosed |
| US-7595420-B2 | Hydrogenation of benzene polycarboxylic acids or derivatives thereof | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2009-09-29 | — | — | US | disclosed |
| US-20090234152-A1 | Hydrogenation of Benzene Polycarboxylic Acids or Derivatives Thereof | EXXONMOBIL CHEMICAL PATENTS INC. | 2009-09-17 | — | — | US | disclosed |
| US-20060247461-A1 | Hydrogenation of benzene polycarboxylic acids or derivatives thereof | EXXONMOBIL CHEMICAL PATENTS INC. | 2006-11-02 | — | — | US | disclosed |
| US-20060149097-A1 | Hydrogenation processes | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY | 2006-07-06 | — | — | US | disclosed |
| EP-1567470-A1 | HYDROGENATION OF BENZENE POLYCARBOXYLIC ACIDS OR DERIVATIVES THEREOF | ExxonMobil Chemical Patents Inc. (US) | 2005-08-31 | — | — | EP | disclosed |
| WO-2004046078-A1 | HYDROGENATION OF BENZENE POLYCARBOXYLIC ACIDS OR DERIVATIVES THEREOF | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2004-06-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060149097-A1 | Hydrogenation processes | HAO2, HVCN1, AOC3 | PRKCA 4298/4885PRKCD 4077/4885MAPT 3739/4885 |
| US-20100184895-A1 | Hydrogenation Processes | HAO2, HVCN1, AOC3 | PRKCA 4298/4885PRKCD 4077/4885MAPT 3739/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.